Time course and biologic correlates of treatment response in first-episode schizophrenia.
about
The myth of schizophrenia as a progressive brain diseaseHaloperidol dose for the acute phase of schizophreniaAntipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanismsAlterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant SchizophreniaMagnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future researchAll Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High ReceptorsAntipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotectionHaloperidol dose for the acute phase of schizophrenia.Appraising evidence for intervention effectiveness in early psychosis: conceptual framework and review of evaluation approaches.Improving outcome in schizophrenia: the case for early interventionEpilepsy, schizophrenia, and the extended amygdala.Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophreniaIs phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome?Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia.Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial.Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 yearsRisperidone versus haloperidol in acute and transient psychotic disorder.Reasoning about the optimal duration of prophylactic antipsychotic medication in schizophrenia: evidence and arguments.Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders.The nature of relapse in schizophrenia.The long-term effects of placebo in patients with chronic schizophrenia.State of the art of drug treatment of schizophrenia and the future position of the novel/atypical antipsychotics.Understanding antipsychotic "atypicality": a clinical and pharmacological moving targetRemission and recovery during the first outpatient year of the early course of schizophrenia.Long acting injection versus oral risperidone in first-episode schizophrenia: differential impact on white matter myelination trajectory.Sex-dependent modulation of treatment responseTime to treatment response in first-episode schizophrenia: should acute treatment trials last several months?Is early intervention for psychosis feasible and effective?Investigating the neurodevelopmental hypothesis of schizophrenia.The impact of subjective well-being under neuroleptic treatment on compliance and remission.Is active psychosis neurotoxic?Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia.Factors that influence the prescription of antipsychotics for patients with schizophrenia in chinaTreatment Response in First-episode Schizophrenia.Neuroimaging of schizophrenia: structural abnormalities and pathophysiological implicationsWhen should clozapine be initiated in schizophrenia?: Some arguments for and against earlier use of clozapine.Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics.Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature.Clinical recovery in first-episode psychosisEfficacy and Tolerability of Paliperidone Extended-release in the Treatment of First-episode Psychosis: An Eight-week, Open-label, Multicenter Trial.
P2860
Q24067152-65C4C799-3BA3-4725-89FA-D8EBFFA77E3EQ24200200-114DA4EB-05BD-4436-951A-4C530F0AF450Q26745506-47BEC8D3-E248-43EB-8921-61E16C7BF080Q26773403-F7B936FD-1642-4F1B-9470-0AA696D21548Q28082090-1FE8D9AF-4A2E-4570-93BF-9B41A3C5B8BEQ29395121-E12A5142-6F05-472C-B2C7-0E65DF3B6C35Q30386608-46CC861E-14D3-4929-9670-F23341F4F45BQ30838771-1D1BFDF3-5615-4C85-82F4-3001DADCC783Q33533853-92661448-6BB3-48AE-924A-3324AF720FEDQ33585800-99B13411-2CD6-402A-AA51-65A2A76EEFFCQ33692855-A9CD95E2-E160-4611-A851-83A73451EF39Q33759300-CF5FDCFE-2570-4BDF-BCDF-77479A6503B4Q33870572-60809099-CA77-4890-A8FF-3AB73D3B9880Q34041815-B55024F7-59B5-449A-9BB5-F4946676B8C8Q34075734-E9428A9A-D3C8-4C68-AA26-F2FB8465247EQ34092686-79B96EB6-1FF1-43C6-B86F-8A7389BCF35EQ34218304-8FCBDD58-E9B1-4CC1-B1E6-C1855F159E9BQ34266206-043AB699-35CE-46E7-8BD5-D2E517963656Q34386214-43FFA24F-61F2-4866-AB21-210FBEDFF9E4Q34581127-65048FCB-0959-42F9-B338-60CB0B69B293Q35001321-4E5E82B1-357C-4DBD-95C0-D572509A8362Q35073834-798A64C3-F6DB-4AFC-845B-78343C51A392Q35200831-A79F59D6-C13C-4C02-8509-EC05DF4D135CQ35211161-97A3CEBE-BDD9-4653-8CCA-C21E15AC244FQ35211261-F069B24D-A23A-4E22-8D61-4BF9B41827DEQ35236761-7A586F39-E576-4773-B95F-C86829B3AFCFQ35635609-E9A12BE0-AEC2-4348-BCA8-12D21A9C3A17Q36201294-0591FB18-19A8-4B2E-B651-3EB70EED253FQ36262192-F5DDEAA1-412F-49E0-B951-503F1E3DB034Q36460707-70C83EC7-C7B1-4A24-8731-D29E663E0C35Q36568049-28728975-3179-42EE-A89F-9BE0CDDDB4D3Q36597061-A1B29C27-8E93-4CF4-BD72-4891DF5926FFQ36600672-7F1A343E-82CD-4F7C-B8ED-C8FD67E07BE6Q36600801-08FF2904-0E9D-490E-B6B4-052486147985Q36703795-B5ACEE3C-FD14-4D3C-B7C2-1D3D5091AACDQ36768035-1D90A4BB-7099-4181-BB7F-4C967638B480Q36853291-FD4274C1-D524-4C91-B76B-1FCA5BB04283Q37106946-15F3C019-97A7-4092-AC97-61E4795E77EEQ37137014-E4D7E477-CD6E-4C90-A9AC-9740905C100FQ37160642-07DCA00A-5E4D-4A2D-A3C6-DB3019F9F613
P2860
Time course and biologic correlates of treatment response in first-episode schizophrenia.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Time course and biologic correlates of treatment response in first-episode schizophrenia.
@en
Time course and biologic correlates of treatment response in first-episode schizophrenia.
@nl
type
label
Time course and biologic correlates of treatment response in first-episode schizophrenia.
@en
Time course and biologic correlates of treatment response in first-episode schizophrenia.
@nl
prefLabel
Time course and biologic correlates of treatment response in first-episode schizophrenia.
@en
Time course and biologic correlates of treatment response in first-episode schizophrenia.
@nl
P2093
P1433
P1476
Time course and biologic correlates of treatment response in first-episode schizophrenia.
@en
P2093
Borenstein M
Lieberman J
Szymanski S
P304
P356
10.1001/ARCHPSYC.1993.01820170047006
P407
P577
1993-05-01T00:00:00Z